Eli Lilly and CompanyVerified account

@LillyPad

Lilly unites caring with discovery to create medicines that make life better for people around the world.

Indianapolis, IN
Joined July 2010

Tweets

You blocked @LillyPad

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @LillyPad

  1. Pinned Tweet
    Mar 1

    If you or someone you know has difficulty paying for Lilly insulin, we have a comprehensive suite of insulin affordability solutions available. We want to help:

    Undo
  2. means nearly everyone has an Alzheimer’s story to tell. Just like , we hear you. We’re with you. And we’re not giving up.

    Undo
  3. Lilly continues to support relief efforts in Ukraine and has shifted its operational focus in Russia. For more information, visit .

    Undo
  4. The 's preparedness for the next pandemic can be strengthened through this year's PDUFA legislation. Learn how PDUFA can get us ahead of the next inevitable public health crisis:

    Undo
  5. Mar 8

    doesn't receive the same level of diagnosis, insurance coverage or care support as other chronic diseases in the U.S. Read about the stigmas and misperceptions that fuel these challenges.

    Undo
  6. Mar 4

    is often misunderstood as being solely the responsibility of those living with the disease, but there’s more to the story. This we’re highlighting our work to uncover the root of these biases and spark change.

    Undo
  7. Mar 3

    Lilly is providing $9.3 million in lifesaving medicines to and . Learn more:

    Undo
  8. Mar 1

    Julia, a Lilly senior medical advisor, and her team are conducting research to better understand misperceptions about , so we can help overcome them.

    Undo
  9. has been recognized as a disease by the for nearly a decade, but approaches to care remain inconsistent and limited. We’re investigating the barriers to comprehensive care for people living with obesity.

    Undo
  10. Feb 24

    NEWS – This Heart Month, we’re proud to announce the has approved our medication with as a new therapeutic option for the millions of adults with . More info:

    Undo
  11. Dr. Paul Farmer reinforced to us the importance of global health, diversity of partnerships, vision and humanity. Farmer’s work on drug-resistant TB in Peru in the 1990s helped spark our global health work that continues today.

    Undo
  12. Lilly is investing $700 million to establish the Institute for Genetic Medicine in Boston. Researchers will focus on therapies that target the root cause of some of the world’s most devastating diseases.

    Undo
  13. New Phase 3 data shared at show an investigational Lilly medicine achieved the primary and all key secondary endpoints in a clinical trial of people living with moderately-to-severely active ulcerative colitis. Learn more:

    Undo
  14. Lilly is collaborating with , , , and to launch an education campaign that provides resources for understanding the complexities of early breast cancer.

    Undo
  15. The has granted Emergency Use Authorization for another investigational antibody for the treatment of mild to moderate COVID-19 in high-risk patients. Learn more:

    Undo
  16. Feb 3

    Driven by our newest innovations, Lilly medicines helped make life better for over 47 million people worldwide last year. But it's where we’re going that most excites us. Read about our 2021 financial results:

    Undo
  17. Feb 2

    We appreciate the opportunity to collaborate with this world-renowned nonprofit organization and look forward to sharing progress on this lifesaving, four-year commitment.

    Undo
  18. The Human Rights Campaign Foundation gave Lilly a 100 percent rating on the Corporate Equity Index for LGBTQ equality in the workplace for 2022. Read more about how we bring diversity, equity and inclusion to life.

    Undo
  19. Lilly is investing more than $1.5 billion in new manufacturing facilities in Concord, N.C. and Limerick, Ireland, allowing us to continue to produce today’s medicines while providing additional capacity to manufacture the medicines of tomorrow. Read more:

    Undo
  20. Data shared at from Lilly’s CONFIDE Study reveal the challenges of living with moderately-to-severely active ulcerative colitis. Learn how bowel urgency-related accidents impact those living with this disruptive disease.

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·